Analysis of the causes of the misdiagnosis of hereditary spherocytosis

Ma,Shiyue; Deng,Xuelian; Liao,Lin; Deng,Zengfu; Qiu,Yuling; Wei,Hongying; Lin,Faquan

doi:10.3892/or.2018.6578

Analysis of the causes of the misdiagnosis of hereditary spherocytosis

Authors:
- Shiyue Ma
- Xuelian Deng
- Lin Liao
- Zengfu Deng
- Yuling Qiu
- Hongying Wei
- Faquan Lin
View Affiliations

Affiliations: Department of Clinical Laboratory, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, Zhuang Autonomous Region, P.R. China, Department of Pediatric Laboratory, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, Zhuang Autonomous Region, P.R. China
Published online on: July 13, 2018 https://doi.org/10.3892/or.2018.6578
Pages: 1451-1458

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Hereditary spherocytosis (HS) is an inherited hemolytic disease with clinical diversities. The aim of the present study was to examine the reasons for prolonged misdiagnosis and mistherapy of HS in a Chinese patient, and to summarize the laboratory screening and treatment methods for this disease in increasing the knowledge towards HS. Clinical data of the proband was reviewed. The proband was first screened by detection of eosin-5'-maleimide (EMA)-labeled red blood cells (RBCs) using flow cytometry. The type of protein defect in the extracted RBC membrane proteins was confirmed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Mutant fragments were verified using direct DNA sequencing and matrix-assisted laser desorption/ionization time of flight (MALDI-TOF) mass spectroscopy. The proband showed a significant hemolytic tendency and significant reduction in the number of EMA-labeled RBCs. DNA sequencing indicated three site mutations in the SPTA1 gene, including His54Pro, Leu1858Val and 6531-12C>T. Additional DNA analysis of the three mutations in the parents of the proband showed that both the Leu1858Val and 6531‑12C>T mutations were carried by the father and the His54Pro mutation was carried by the mother. Moreover, the mutated peptides were identified by MALDI-TOF mass spectroscopy. HS has diverse clinical manifestations and is easily missed, misdiagnosed and mistreated. Therefore, a comprehensive analysis involving a routine blood test, blood smear, EMA labeling (flow cytometry) and SDS-PAGE can effectively distinguish HS from thalassemia, glucose-6-phosphate deficiency, iron-deficiency anemia and autoimmune hemolytic anemia.

View Figures

View References

1	Yawata Y, Kanzaki A, Yawata A, Doerfler W, Ozcan R and Eber SW: Characteristic features of the genotype and phenotype of hereditary spherocytosis in the Japanese population. Int J Hematol. 71:118–135. 2000.PubMed/NCBI
2	Bolton-Maggs PH, Langer JC, Iolascon A, Tittensor P and King MJ; General Haematology Task Force of the British Committee for Standards in Haematology, : Guidelines for the diagnosis and management of hereditary spherocytosis − 2011 update. Br J Haematol. 156:37–49. 2012. View Article : Google Scholar : PubMed/NCBI
3	King MJ, Garçon L, Hoyer JD, Iolascon A, Picard V, Stewart G, Bianchi P, Lee SH and Zanella A; International Council for Standardization in Haematology, : ICSH guidelines for the laboratory diagnosis of nonimmune hereditary red cell membrane disorders. Int J Lab Hematol. 37:304–325. 2015. View Article : Google Scholar : PubMed/NCBI
4	Ciepiela O, Kotuła I, Górska E, Stelmaszczyk-Emmel A, Popko K, Szmydki-Baran A, Adamowicz-Salach A and Demkow U: Delay in the measurement of eosin-5′-maleimide (EMA) binding does not affect the test result for the diagnosis of hereditary spherocytosis. Clin Chem Lab Med. 51:817–823. 2013. View Article : Google Scholar : PubMed/NCBI
5	Rungaldier S, Oberwagner W, Salzer U, Csaszar E and Prohaska R: Stomatin interacts with GLUT1/SLC2A1, band 3/SLC4A1, and aquaporin-1 in human erythrocyte membrane domains. Biochim Biophys Acta. 1828:956–966. 2013. View Article : Google Scholar : PubMed/NCBI
6	Fairbanks G, Steck TL and Wallach DF: Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane. Biochemistry. 10:2606–2617. 1971. View Article : Google Scholar : PubMed/NCBI
7	Gharahdaghi F, Weinberg CR, Meagher DA, Imai BS and Mische SM: Mass spectrometric identification of proteins from silver-stained polyacrylamide gel: A method for the removal of silver ions to enhance sensitivity. Electrophoresis. 20:601–605. 1999. View Article : Google Scholar : PubMed/NCBI
8	Richards CS, Bale S, Bellissimo DB, Das S, Grody WW, Hegde MR, Lyon E and Ward BE; Molecular Subcommittee of the ACMG Laboratory Quality Assurance Committee, : ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007. Genet Med. 10:294–300. 2008. View Article : Google Scholar : PubMed/NCBI
9	Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al ACMG Laboratory Quality Assurance Committee, : Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 17:405–424. 2015. View Article : Google Scholar : PubMed/NCBI
10	Li MM, Datto M, Duncavage EJ, Kulkarni S, Lindeman NI, Roy S, Tsimberidou AM, Vnencak-Jones CL, Wolff DJ, Younes A, et al: Standards and guidelines for the interpretation and reporting of sequence variants in cancer: A joint consensus recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists. J Mol Diagn. 19:4–23. 2017. View Article : Google Scholar : PubMed/NCBI
11	Hunt L, Greenwood D, Heimpel H, Noel N, Whiteway A and King MJ: Toward the harmonization of result presentation for the eosin-5′-maleimide binding test in the diagnosis of hereditary spherocytosis. Cytometry B Clin Cytom. 88:50–57. 2015. View Article : Google Scholar : PubMed/NCBI
12	Manciu S, Matei E and Trandafir B: Hereditary spherocytosis - diagnosis, surgical treatment and outcomes. A literature review. Chirurgia (Bucur). 112:110–116. 2017. View Article : Google Scholar : PubMed/NCBI
13	Barcellini W, Bianchi P, Fermo E, Imperiali FG, Marcello AP, Vercellati C, Zaninoni A and Zanella A: Hereditary red cell membrane defects: Diagnostic and clinical aspects. Blood Transfus. 9:274–277. 2011.PubMed/NCBI
14	Guillaud C, Loustau V and Michel M: Hemolytic anemia in adults: Main causes and diagnostic procedures. Expert Rev Hematol. 5:229–241. 2012. View Article : Google Scholar : PubMed/NCBI
15	Broséus J, Visomblain B, Guy J, Maynadié M and Girodon F: Evaluation of mean sphered corpuscular volume for predicting hereditary spherocytosis. Int J Lab Hematol. 32:519–523. 2010. View Article : Google Scholar : PubMed/NCBI
16	Liao L, Deng ZF, Qiu YL, Chen P, Chen WQ and Lin FQ: Values of mean cell volume and mean sphered cell volume can differentiate hereditary spherocytosis and thalassemia. Hematology. 19:393–396. 2014. View Article : Google Scholar : PubMed/NCBI
17	Kar R and Sharma CB: Bilirubin peak can be mistaken as Hb Bart's or Hb H on High-performance liquid chromatography. Hemoglobin. 35:171–174. 2011. View Article : Google Scholar : PubMed/NCBI
18	Tao YF, Deng ZF, Liao L, Qiu YL, Chen WQ and Lin FQ: Comparison and evaluation of three screening tests of hereditary spherocytosis in Chinese patients. Ann Hematol. 94:747–751. 2015. View Article : Google Scholar : PubMed/NCBI
19	Lazarova E, Pradier O, Cotton F and Gulbis B: Automated reticulocyte parameters for hereditary spherocytosis screening. Ann Hematol. 93:1809–1818. 2014. View Article : Google Scholar : PubMed/NCBI
20	Xu Y, Yang W, Liao L, Deng Z, Qiu Y, Chen W and Lin F: Mean reticulocyte volume: A specific parameter to screen for hereditary spherocytosis. Eur J Haematol. 96:170–174. 2016. View Article : Google Scholar : PubMed/NCBI
21	Deng Z, Liao L, Yang W and Lin F: Misdiagnosis of two cases of hereditary spherocytosis in a family and review of published reports. Clin Chim Acta. 441:6–9. 2015. View Article : Google Scholar : PubMed/NCBI
22	King MJ and Zanella A: Hereditary red cell membrane disorders and laboratory diagnostic testing. Int J Lab Hematol. 35:237–243. 2013. View Article : Google Scholar : PubMed/NCBI
23	Wang J, Zheng B, Zhao Y, Chen X, Liu Y, Bo L, Zheng Y, Zhang F, Ru K and Wang H: Flow cytometric test using eosin-5′-maleimide (EMA) labelling of red blood for diagnosis of hereditary spherocytosis. Zhonghua Xue Ye Xue Za Zhi. 36:598–601. 2015.(In Chinese). PubMed/NCBI
24	Suemori S, Wada H, Nakanishi H, Tsujioka T, Sugihara T and Tohyama K: Analysis of hereditary elliptocytosis with decreased binding of eosin-5-maleimide to red blood cells. BioMed Res Int. 2015:4518612015. View Article : Google Scholar : PubMed/NCBI
25	Joshi P, Aggarwal A, Jamwal M, Sachdeva MU, Bansal D, Malhotra P, Sharma P and Das R: A comparative evaluation of Eosin-5′-maleimide flow cytometry reveals a high diagnostic efficacy for hereditary spherocytosis. Int J Lab Hematol. 38:520–526. 2016. View Article : Google Scholar : PubMed/NCBI
26	Perrotta S, Della Ragione F, Rossi F, Avvisati RA, Di Pinto D, De Mieri G, Scianguetta S, Mancusi S, De Falco L, Marano V, et al: Beta-spectrinBari: A truncated beta-chain responsible for dominant hereditary spherocytosis. Haematologica. 94:1753–1757. 2009. View Article : Google Scholar : PubMed/NCBI
27	Serpillon S, Floyd BC, Gupte RS, George S, Kozicky M, Neito V, Recchia F, Stanley W, Wolin MS and Gupte SA: Superoxide production by NAD(P)H oxidase and mitochondria is increased in genetically obese and hyperglycemic rat heart and aorta before the development of cardiac dysfunction. The role of glucose-6-phosphate dehydrogenase-derived NADPH. Am J Physiol Heart Circ Physiol. 297:H153–H162. 2009. View Article : Google Scholar : PubMed/NCBI
28	Perrotta S, Gallagher PG and Mohandas N: Hereditary spherocytosis. Lancet. 372:1411–1426. 2008. View Article : Google Scholar : PubMed/NCBI
29	Da Costa L, Galimand J, Fenneteau O and Mohandas N: Hereditary spherocytosis, elliptocytosis, and other red cell membrane disorders. Blood Rev. 27:167–178. 2013. View Article : Google Scholar : PubMed/NCBI
30	Adzhubei I, Jordan DM and Sunyaev SR: Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet Chapter. 7:Unit7.20. 2013.
31	Maréchal J, Wilmotte R, Kanzaki A, Dhermy D, Garbarz M, Galand C, Tang TK, Yawata Y and Delaunay J: Ethnic distribution of allele alpha LELY, a low-expression allele of red-cell spectrin alpha-gene. Br J Haematol. 90:553–556. 1995. View Article : Google Scholar : PubMed/NCBI
32	Randon J, Boulanger L, Marechal J, Garbarz M, Vallier A, Ribeiro L, Tamagnini G, Dhermy D and Delaunay J: A variant of spectrin low-expression allele alpha LELY carrying a hereditary elliptocytosis mutation in codon 28. Br J Haematol. 88:534–540. 1994. View Article : Google Scholar : PubMed/NCBI
33	Tolpinrud W, Maksimova YD, Forget BG and Gallagher PG: Nonsense mutations of the alpha-spectrin gene in hereditary pyropoikilocytosis. Haematologica. 93:1752–1754. 2008. View Article : Google Scholar : PubMed/NCBI